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Members of the genus Brucella cluster in two phylogenetic groups: classical and
non-classical species. The former group is composed of Brucella species that cause
disease in mammals, including humans. A Brucella species, labeled as Brucella
sp. BCCN84.3, was isolated from the testes of a Saint Bernard dog suffering
orchiepididymitis, in Costa Rica. Following standard microbiological methods, the
bacterium was first defined as “Brucella melitensis biovar 2.” Further molecular typing,
identified the strain as an atypical “Brucella suis.” Distinctive Brucella sp. BCCN84.3
markers, absent in other Brucella species and strains, were revealed by fatty acid
methyl ester analysis, high resolution melting PCR and omp25 and omp2a/omp2b gene
diversity. Analysis of multiple loci variable number of tandem repeats and whole genome
sequencing demonstrated that this isolate was different from the currently described
Brucella species. The smooth Brucella sp. BCCN84.3 clusters together with the classical
Brucella clade and displays all the genes required for virulence. Brucella sp. BCCN84.3
is a species nova taxonomical entity displaying pathogenicity; therefore, relevant for
differential diagnoses in the context of brucellosis. Considering the debate on theBrucella
species concept, there is a need to describe the extant taxonomical entities of these
pathogens in order to understand the dispersion and evolution.
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INTRODUCTION
The Brucella genus comprises two phylogenetically related
clusters: classical and non-classical (1). The former cluster is a
compact group composed of Brucella melitensis, Brucella abortus,
Brucella suis, Brucella canis, Brucella neotomae, Brucella ceti,
Brucella pinnipedialis, Brucella ovis, Brucella microti, Brucella
papionis, and Brucella sp. F5/99. All these species infect
and produce disease in mammals, displaying host preference.
Members of this cluster are non-motile, devoid of plasmids and
their genomes show nucleotide identities of >99% (1, 2). The
first six Brucella species of this cluster are zoonotic and can infect
humans (3–5).
Non-classical Brucella species, also known as the “BO clade,”
cluster in a discrete group that includes the fast-growing Brucella
inopinata and BO2 strains isolated in humans as well as Brucella
species living in frogs (1). Brucella vulpis, isolated from red
foxes in Australia, is more distant to BO clade and contains
unique genetic information related to soil bacteria not encoded
in classical Brucella organisms (1). Bacteria of the BO clade
and B. vulpis display nucleotide identities of 97–98% with
those of the classical clade. The species of this cluster also
share genes with the soil bacteria Ochrobactrum spp. and show
key sequence differences in central genes such as 16S rRNA
and recA, as distinctive features (1). With the sole exception
of B. inopinata, these Brucella species possess an O-chain
lipopolysaccharide (LPS) structure that departs from that of
the classical Brucella species (1, 6). This feature hampers the
straightforward recognition of non-classical Brucella infections
in animals.
Identification of the classical Brucella species and strains
by traditional bacteriological and molecular methods is not
straightforward. This is due to the high phenotypic and genotypic
resemblance among different members of the genus (3, 7).
TABLE 1 | Microbiological characterization of Brucella sp. BCCN84.3 and comparison with Brucella reference strains.
Strains RTD phage lysisa CO2
requirement
Urease Serum agglutination againstb Growth on dyes, µg/mLc
Tb Wb Iz R/C A M Thionin Basic fuchsin O safranin
10 20 10 20 100
Brucella sp. BCCN84.3d – + + – No + + – + + + +c +
B. abortus 2308W + + + – No + + – – – + + +
B. suis 1330 – + + – No + + – + + – – –
B. melitensis 16M – – + – No + – + + + + + +
B. ovis 63/290 – – – + Yes + – – + – – – –
B. canis CR12 – – – + No + – – + – – – –
B. neotomae 5K/33 + – + + No + + – – – – –
B. microti CCM 4915 – + No + – + + + + +
B. ceti, B1/94 – + – – No + + – + + + + +
B. pinnipedialis B2/94 – – + – Yes + + – + + + + +
aRTD, routine test dilution of phages Tbilisi (Tb), Weybridge (Wb), Izatnagar (Iz), and rough type Wb derivative (R/C).
bSerum against LPS epitopes, measured as agglutination with monospecific serum.
cDye concentrations expressed in µg/mL of culture medium and plates incubated under 10% CO2 atmosphere.
dThe strain was oxidase positive and readily produced H2S.
For this reason, many Brucella strains isolated from various
animal species have been misclassified or not fully characterized
(8, 9). One clear example of clinical relevance has been the
discovery of B. neotomae as a human pathogen, which was
wrongly classified as an atypical B. abortus strain by classical
bacteriological methods (10). With the advent of sophisticated
molecular tools and whole genome sequence analysis (WGSA),
the correct identification of Brucella species was achieved (1, 4).
Here, we describe the phenotypic and genotypic properties of
a new classical pathogenic smooth Brucella sp., isolated from a
Saint Bernard dog suffering orchiepididymitis. After its primary
isolation in 1984 in Costa Rica (11), the strain was first assigned
as an atypical strain of B. melitensis biovar 2 (12).
MATERIALS AND METHODS
Clinical Case and Bacterial Isolation
A 4-year male domestic Saint Bernard dog from the Central
Valley of Costa Rica showing testicular lesions, was brought to
the Hospital of the Veterinary School of the National University,
in 1984. After hospitalization, the owner was informed of all
procedures and clinical studies and gave her written consent.
All protocols and actions undertaken to diagnose the disease
were under the Veterinary Hospital guidance established in 1980.
The protocols used in 1984, were those approved by the “Ley
General de Salud” N◦ 5395, and “Disposiciones sobre Matrícula y
Vacunación de Perros” N◦ 2391.
After anamnesis and clinical examination, the dog was
subjected to surgery and both testes removed. Rose Bengal test
(13) was used to determine the presence of antibodies against
smooth Brucella. Histopathological examination of the testes
was performed following previous protocols (14). For bacterial
isolation, blood and testicular samples were cultured in blood-
agar plates. The plates were incubated at 37◦C under the presence
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or the absence of 10% CO2 atmosphere. The bacterial colonies
were identified as Brucella sp. at the Bacteriology Laboratory
of INCIENSA, Costa Rica (11). The isolate (code Brucella
sp. BCCN84.3) was freeze-dried and submitted for further
bacteriological and molecular typing, as described below.
Bacterial Phenotypic Characterization
The Brucella sp. BCCN84.3 was subjected to classical
bacteriological typing (Table 1) following established protocols
(13). Reference Brucella strains were used for comparative
purposes (Supplementary Table 1). Total lipids were extracted
and analyzed as described elsewhere (15) and resolved on silica
gel 60 high-performance TLC plates (Merck Chemicals) using
n-propanol/propionic acid/chloroform/water (3:2:2:1) and
developed by charring with 15% (v/v) sulfuric acid in ethanol
(16). Processing of the fatty acid methyl ester for taxonomical
identification and dendrogram assembly were carried out as
described before (17). Extraction of LPS by SDS-proteinase
K protocol was performed as described previously (18). LPS
was analyzed in 12 or 15% polyacrylamide gels and stained
by the periodate-alkaline silver method (19). An immune
serum obtained from B. melitensis 16M infected rabbits (20),
either plain or absorbed with cells from rough Per mutant
strain derived from B. abortus 2308W, was used for assessing
anti-smooth-LPS reactivity. Immune serum obtained from B.
abortus Per immunized rabbit (21) was used for anti-rough-
LPS reactivity. Western blots and ELISA with a collection of
monoclonal antibodies (Mabs) for the detection of specific
Brucella surface antigens were performed as described elsewhere
(22, 23). Susceptibility to polymyxin B was determined by
estimating the minimal inhibitory concentration on Müller-
Hinton agar (Becton Dickinson, Izasa), following the e-test
(Liofilchem, Werfen) method (24).
Genotypic and
Phylogenetic Characterization
Bacterial DNA was extracted with DNeasy Blood & Tissue kit
from QIAGEN or Promega Wizard Genomic DNA Purification
kit as per manufacturer’s instructions. DNA was stored at−70◦C
until used. Bruce-ladder v2.0 PCR for the differentiation of
Brucella species and strains was carried following previous
protocols (25). Suis-ladder PCR assay for B. suis biovar typing
and the discrimination of B. suis and B. canis was performed as
described before (26).
Two different real-time PCRs, for the detection of Brucella
genus and B. suis were performed as previously described (27).
Additionally, two different high-resolution melting PCR assays
(HRM-PCR) for the specific detection and discrimination of
B. canis and B. melitensis were performed following previous
protocols (27), using a DNA concentration of 1.5 ng/µL and a
Type-it HRM-PCR Kit (QIAGEN) in a reaction volume of 25 µL
with a Rotor-Gene Q (QIAGEN). Control DNAs from B. canis
RM 6/66, B. melitensis 16M, B. suis 1330 and B. neotomae 5K/33
were extracted with DNeasy Blood & Tissue kit from QIAGEN,
and stored at −80◦C until used. The conditions were one cycle
at 50◦C for 2min and one cycle at 95◦C for 10min, followed by
40 cycles at 95◦C for 5 s and a cycle at 60◦C for 30 s, with data
FIGURE 1 | Typification of Brucella sp. BCCN84.3 by Bruce-ladder and
Suis-Ladder. (A) Bruce-ladder analysis does not distinguish between B. suis
species and BCCN84.3. (B) Suis-Ladder identified a characteristic pattern for
Brucella sp. BCCN84.3, different from those of B. suis and B. canis.
acquired at 60◦C in the green channel. After amplification, an
HRM-PCR was performed when needed from 73 to 88◦C at a
rate of 0.03◦C per step.
Multiple loci variable number of tandem repeats analysis
(MLVA16) and the corresponding cladograms were generated
according to described protocols (17, 28) using the MLVA-NET
database (29). Values obtained for each MLVA16 marker are in
Supplementary Data Sheet 1.
WGSA was performed at the Wellcome Trust Sanger
Institute on Illumina platforms according to in-house protocols
(30, 31). For WGSA assembly and alignment sequencing
reads were de novo assembled using a Velvet Optimiser
(32). In order to overcome possible genome deviation
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through serial cultivation, the strain deposited in 1984 in
the Brucella Culture Collection Nouzilly (BCCN) was also
sequenced and deposited at DDBJ/ENA/GenBank under the
accession NQLX00000000; Accession Brucella sp. BCCN84.3
(NQLX00000000; BioSample SAMN07488835). WGSA from
representative Brucella strains used for comparative purposes
were obtained from GenBank (Supplementary Data Sheet 1).
Low length and N50 scaffold sequences were not included
in the analysis. Automatic annotation of the assembly was
performed with the Prokka program (33). Genome sequence
data was deposited at the European Nucleotide Archive under
accession code ERS568777 and at DDBJ/ENA/GenBank under
the accession NQLX00000000; BioSample SAMN07488835
(Supplementary Data Sheet 1). The 9 and 21 loci schemes
of Multi Locus Sequence typing (MLST) were performed in
silico by BLAST comparison with a set of specific primers
(34) and the assembled scaffolds as input. The results were
confirmed by querying the matched sequences or “amplicons”
at the Brucella MLST Database (https://pubmlst.org/brucella/)
(Supplementary Data Sheet 1).
Phylogenetic Reconstruction
Two Ochrobactrum species and Brucella isolates were used for
phylogenetic reconstruction (Supplementary Data Sheet 1). The
25 WGSA were aligned by bwa and mapped with SMALT v.0.7.4
against B. suis 1330, with an average mapping of 89.41% when
excluding Ochrobactrum. Single Nucleotide Polymorphisms
(SNPs) were called using SAMtools (35), and 451213 variable
sites were extracted using SNP sites (36). The general features
of all 25 assemblies annotated by Prokka were used to perform
TABLE 2 | Cell envelope characteristics of Brucella sp. BCCN84.3 and comparison with reference Brucella strains.
Major lipids Reactivity with serum to Resistance to cationic peptides
(PmxB MIC µg/ml)
Phospholipids Aminolipids O-chain R-LPS
Brucella sp. BCCN84.3 PC; PE; PG; CL OL A>M + 12
B. canis CR12 PC; PE; PG; CL OL – + 12
B. microti CCM 4915 PC; PE; PG; CL OH-OL; OL A>M – >16
B. melitensis 16M PC; PE; PG; CL OL M>A + 16
B. suis 1330 PC; PE; PG; CL OL A>M + 16
B. abortus 2308W PC; PE; PG; CL OL A>M + 4
PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglicerol; CL, cardiolipine, OL, ornithine lipids; OH-OL, hydroxylated ornithine lipids: PmxB, polymixin B.
FIGURE 2 | Dendrogram of the fatty acid methyl esters of different Brucella extracts. Notice that the Brucella sp. BCCN84.3 stands alone in relation to the classical
species. For values of retention times of fatty acid methyl esters (see Supplementary File 2).
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a pangenome analysis (36). Both SNPs and core genome
alignments were individually used to each produce a maximum
likelihood phylogenetic reconstruction with RAxML v8.2 (37).
The phylogenetic trees were rooted usingOchrobactrum anthropi
ATCC49188 and Ochrobactrum intermedium LMG3301.
A Specific Search for Regions of Interest
Regions of interest were searched through bwa alignment
and SMALT mapping, or BLAST comparison against B. canis
ATCC RM6/66 (NC_010103.1-NC_010104.1), B. suis 1330
(NC_004310.3-NC_004311.2), B. abortus 9-941 (NC_006932.1-
NC_006933.1), B. abortus 2308W (ERS568782), B. melitensis
16M (NC_003317.1-NC_003318.1), and B. microti CCM 4915
FIGURE 3 | HRM-PCR analysis of Brucella sp. BCCN84.3. (A) HRM-PCR
assay using primers designed for B. canis (A) or B. melitensis (B) (27) clearly
show that Brucella sp. BCNN84.3 has an HRM profile different from other
classical Brucella species.
(NC_013119.1-NC_013118.1). The number of SNPs, insertions
and deletions in each gene were recorded. BLAST comparisons
between Brucella sp. BCCN84.3, B. canisRM6/66 and B. suis 1330
were performed and visualized with the Artemis Comparison
Tool (38). The presence of recombination events was analyzed
by Genealogies Unbiased By recomBinations In Nucleotide
Sequences (39) and visualized by Phandango (40). Southern blot
analysis was performed as described previously (41) using the IS
elements IS711 and ISBme1 as probes on EcoR1-digested DNA.
For phylogenetic reconstruction, comparisons among
omp2a (BAW_10633) and omp2b (BAW_10634) porin gene
sequences were assessed through multiple sequence alignments.
Characterization of Omp2a and omp2b have been used as
molecular tools for the description of Brucella species since 2007
(42), Sanger sequence data from 14 classical Brucella strains
were visualized, edited, aligned, and analyzed in MEGA version
7 (43). The resulting alignment of 1,223 positions was used to
build a phylogenetic tree by the maximum likelihood method
based on the Tamura-Nei model (44). The tree with the highest
log likelihood was selected. All the positions containing gaps or
missing data were eliminated. Initial trees for the heuristic search
were obtained automatically by applying the Neighbor-Join and
BioNJ algorithms to a matrix of pairwise distances estimated
using the maximum composite likelihood approach and then by
selecting the topology with a superior log-likelihood value.
RESULTS
The anamnesis revealed that the Saint Bernard dog was imported
from the United States as a puppy to Costa Rica, in 1980. The
animal lived in the city of Heredia, Costa Rica and was never
in contact with farm animals or mated. Upon arrival to the
Veterinary Medicine School, the dog showed unwillingness to
walk, general lethargy, refusal to eat, aspermia, fever, enlargement
of the scrotum and testicles with local dermatitis and scrotal
pain. The animal did not show any rashes, abdominal pain,
visceral enlargement or local adenopathy. Platelets and leukocyte
counts were normal. Pathological inspection showed bilateral
enlargement of the epididymis and inflammation as well
mild necrosis of both testes. Histopathological examination of
testicular tissue revealed necrotizing foci and granulomatous
inflammation. Since the serum of the animal showed positive
agglutination in Rose Bengal test for brucellosis, it was not
necessary to perform any other serological tests. The presumptive
clinical diagnosis was orchiepididymitis due to brucellosis.
Serological diagnosis was confirmed by isolation of smooth
Brucella sp. from testicular tissue after 1 week of culture in blood
agar. The dog was treated orally with doxycycline (20 mg/Kg),
three times a day for 14 days. Then streptomycin (11 mg/Kg)
was administrated intramuscular every 12 h during 14 days. After
treatment the dog showed improvement; however, the animal
was not followed afterward.
Since the isolate displayed an atypical bacteriological profile
(11), the strain was sent to the Station de Pathologie de la
Reproduction, INRA, Centre de Tours-Nouzilly, France, for
typing. The strain presented an atypical oxidative metabolic
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profile with particularly high levels for L-glutamic acid and
L-asparagine utilization. The strain was coded as Brucella sp.
BCCN84.3 and identified as an atypical B. melitensis biovar 2
(12). Moreover, Bruce-ladder did not distinguish between B. suis
biotype 1 and Brucella sp. BCCN84.3 (Figure 1A). However, the
Brucella sp. BCCN84.3 strain displayed a different Suis-ladder
profile departing from B. suis and B. canis strains (Figure 1B).
Conventional phenotyping did not allow ascription to any
of the currently accepted Brucella nominal species (Tables 1,
2). However, the Brucella sp. BCCN84.3 fatty acid methyl
esters profile suggested a different taxonomical rank (Figure 2).
Likewise, plus-minus real-time PCR analysis using DNA from
Brucella sp. BCCN84.3 was positive for the Brucella genus and
B. suis. HRM-PCR analysis using specific primers for B. canis
(Figure 3A) or B. melitensis (Figure 3B) showed that the profile
of the BCCN84.3 strain was unique as compared to classical
Brucella species.
Following previous experiments (22, 45, 46), no significant
differences in bindings against Brucella sp. BCCN84.3 rough-
LPS, smooth-LPS, Omp2b, Omp19, and Omp31 were detected
by ELISA (Figure 4A). In contrast, when compared with
other brucellae (46), a distinct profile against the Brucella
sp. BCCN84.3 Omp25 was attained (Figure 4A). Mab
A68/04B10/F05 against the Omp25 conformational epitope
reacted with Brucella sp. BCCN84.3, the Mab A76/02C12/C11
(also directed against a conformational epitope, 43) reaction
was negative. A slightly lower molecular weight of the Omp25
was identified in the Brucella sp. BCCN84.3, as compared to
the B. canis and B. abortus counterparts (Figure 4B). This
pattern agrees with the length of omp25 (BAW_10696 locus),
which is slightly shorter than other omp25 genes of classical
Brucella species.
Phylogenetic analysis of the Brucella sp. BCCN84.3 porin
sequences showed a separation in the omp2a and omp2b
corresponding clusters (Figure 5). However, the Brucella sp.
BCCN84.3 omp2awas somewhat closer to the omp2b cluster, due
to a putative recombination event in a region close to the 5′,
which is identical to the porin sequence of the latter (47).
The Brucella sp. BCCN84.3 formed a distinct branch in
relation to other species, as revealed by the MLVA16 analysis
(Figure 6). This result is in agreement with a previous analysis,
using a somewhat different MLVA strategy (48). WGSA
demonstrated that the overall genomic structure of the Brucella
sp. BCCN84.3 isolate corresponds to a new species of classical
brucellae, with a size of 3.26Mb. Parallel sequencing of the
strain conserved in the BCCN collection (named Brucella sp.
BCCN84.3) confirmed the stability of the genome. When both
WGS were compared, no deletions or insertions were found
between the strains and, only three SNPs were detected at
intergenic regions.
As other classical brucellae, Brucella sp. BCCN84.3
presents two chromosomes with no plasmids, no major
recent recombination events (Figure 7) and a similar number
of anomalous regions (Figure 8). The genes encoding for
FIGURE 4 | The binding intensity of a collection of Mabs against Brucella sp. BCCN84.3. (A) A collection Mabs against Brucella Omp31, Omp35, Omp2b, Omp19,
smooth LPS (S-LPS), and rough-LPS (R-LPS) were tested by ELISA against sonicated Brucella sp. BCCN84.3 sonicated cells and the binding compared with B.
abortus or B. melitensis cells. The arrows indicate differential reactivity of both Mabs against a conformational epitope of the Omp25 in comparison to B. abortus or B.
melitensis. For details of the ELISA assay see Cloeckaert et al. (22) (B) WB with Mabs 68/04B10/F05 against Omp25, identifies a slightly lower molecular weight
protein in Brucella sp. BCCN84.3 strain in relation to other classical Brucella species.
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FIGURE 5 | Phylogenetic tree from CLUSTAL Wallis aligned omp2a and omp2b nucleotide sequences of BCCN84.3 and other Brucella strains. The analysis reveals
the separation in BCCN84.3 omp2a and omp2b clusters. The Brucella sp. BCCN84.3 omp2a is somewhat closer to the omp2b cluster; probably due to a
recombination event in the 5′region, which is identical to the latter porin sequence.
virulence factors such as smooth type LPS, VirB operon,
Bac, cyclic glucans, flagellum-like, and BvrR/BvrS system
are conserved (Supplementary Data Sheet 1). The B. canis
genomic island GIFeGSH coding for iron uptake enzymes and
parts of the glutathione pathway (49) is not present in the
Brucella sp. BCCN84.3. Putative genes in loci BAW_10265
coding for the TIR domain-containing protein BtpA claimed
to be a VirB effector of the type IV secretion system and to
modulate microtube dynamics (50), and for putative integrases
(BAW_10237; BAW_10274) are also absent. The manBOAg
(BAW_10538) putatively involved in the synthesis of mannose
of the LPS core (51) was 48 bp shorter than the B. melitensis
(BMEI1396) and about the same size as B. ovis (BOV_0540) and
B. abortus 2308W (BAW_10538) counterparts. The number of
IS711 elements identified by southern blot ranged from 6 to 7.
Due to the repetitive nature of the IS elements, determination
of the exact number by WGSA on Illumina platforms was
not possible.
A total of 205,055 SNPs were found among the Brucella
genomes (Supplementary Data Sheet 1) and were used for
phylogenetic analysis using O. anthropi and O. intermedium
cluster as an outgroup. The general topology of the SNPs
based tree was consistent with previous studies (1). Brucella sp.
BCCN84.3 showed 7,281 polymorphic sites as compared to B.
suis 1330, of those 5,911 were located in coding regions with
a dN/dS ratio of 0.54 (p-value = 0.00). This shows a compact
cluster harboring classical Brucella species and a more dispersed
clade harboring the BO group (Figure 9). Within the classical
cluster, Brucella sp. BCCN84.3 branches alone (Figure 9). This
branching order does not fully agree with the classical MLVA16
dispersion. In silico identical matches of the 9 loci included in
the MLST-9 profile were not able to classify the B. abortus sp.
BCCN84.3 into a sequence type. The-21 loci MLST profile did
not provide more information, 20 loci showed identical match,
except for the ddlA locus, that partially matched to the allele 26,
so no further typing was achieved by this scheme.
DISCUSSION
Canine brucellosis, caused by B. canis, is difficult to diagnose by
serological assays due to the extensive cross-reaction of antigens
with smooth brucellae (52, 53). The unambiguous diagnosis of
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FIGURE 6 | Dendrogram based on MLVA16 analysis of Brucella species and strains representatives. The Brucella sp. BCCN84.3 showed a MLVA16 profile different
from that of the classical smooth Brucella species; consistent with a previous report using a different MLVA strategy (48). MLVA-NET for Brucella. MLVA web service,
CNRS. http://microbesgenotyping.i2bc.paris-saclay.fr/ (accessed 21 December, 2017).
FIGURE 7 | Recombination events in representative Brucella species. Each event is shown by a vertical block ordered along the genome. Upper black line represents
the approximate coordinates in base pairs according to the reference B. suis 1330; each blue line represents a coding sequence in the reference. Red blocks are
recombination events shared by more than two genomes included; blue blocks are unique. Classic Brucella species show few recombination regions; however, a
higher number was detected in the non-classical clades. The Brucella sp. BCCN84.3 is highlighted by a box.
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FIGURE 8 | The presence and absence of anomalous regions or genomic islands in the Brucella genomes. The upper right color scale represents the percentage of
the island present in each genome, where the darker blue color means that the whole region is present. Brucella sp. BCCN84.3 is highlighted by a red box.
B. canis infections is just carried out after the isolation and
identification of the bacterium (14) or molecular typing (26, 54).
In contrast, when positive serological reactions against smooth
brucellae arise in dogs presenting clinical signs of brucellosis,
the presumptive diagnosis seems straightforward and commonly
attributed to B. melitensis, B. abortus or B. suis (55–59). However,
a detailed identification of the smooth Brucella strains isolated
from dogs is seldom performed.
We were unable to trace the source of the Saint Bernard
dog infection. The dog was imported as a puppy from the
United States to Costa Rica. Whether the infection remained
latent or it was acquired de novo in Costa Rica, is unknown.
This is not trivial since there are several reports describing
“atypical B. suis strains” isolated from dogs in different countries,
including in the United States. For instance, in the same year
as the Brucella sp. BCCN84.3 was isolated, a collection of
“atypical B. suis” strains, which were also unusually resistant to
fuchsin, were described in various countries (60). A new B. suis
biovar was suggested for these atypical strains, some of them
isolated from dogs and humans. Likewise, in the same year, an
“atypical B. suis biotype 1” was also isolated in Brazil, from
the testes of a dog suffering orchitis (61). In a survey carried
out in 674 dogs in Georgia, United States, it was established
that nine dogs presented positive serological reactions against
smooth Brucella antigens (58). Brucella organisms were isolated
from the canine testes displaying necrotizing, suppurative
epididymitis and orchitis. After conventional biochemical assays
and 16SrRNA sequencing, the bacterial strains were assigned
to the “B. suis” group. Unfortunately, these latter isolates were
destroyed, precluding any further detailed characterization.More
recently, several dogs were reported to be infected with “B.
suis” in Australia; even though not all dogs were in contact
with wild boars (62). In all these studies the bacterial strains
were identified by conventional methods or rRNA PCR analysis;
though, none of these methods are capable to unambiguously
discern among the various Brucella classical species (63).
The initial bacteriological characterization of the Brucella sp.
BCCN84.3 was also misleading. It was only after genomic
analyses that it became clear that the strain belonged to a new
taxonomic entity.
From the genomic perspective, the Brucella sp. BCCN84.3
is a new taxonomical entity, since it departs phylogenetically
from other strains, being the closest relative B. neotomae but
distinct from this species. The total number of SNPs between
Brucella sp. BCCN84.3 and B. suis 1330 (7281 SNPs) is bigger
than the number between B. suis and B. abortus (6790 SNPs),
two well-recognized species. It is also closer to the number
that separates B. ovis st. IntaBari-2001-319-4082 from B. suis
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FIGURE 9 | Phylogenetic relationship of Brucella sp. BCCN84.3 with other Brucella species and Ochrobactrum sp. Brucella BCCN84.3 results are colored in red.
Branching points with bootstrap values lower than 100 are indicated by a gray dot and small gray font next to it. Segments of the tree were magnified by the use of
Dendroscope version 3.5.8 in order to increase resolution; the adapted scale is indicated next to each magnified region. A blue square highlights all Brucella species;
the classic species are within the upright square, which includes the Brucella sp. BCCN84.3.
st. 1330 (7499 SNPs). Considering the zoonotic potential of
Brucella species, a correct identification by molecular methods
is becoming mandatory. Moreover, in the light of distinct host
preferences (64) and differences in WGSA (1), the various B.
suis strains need to be taxonomically reevaluated, since they
seem to represent a collection of different Brucella species. In
particular B. suis biovar 5 isolated from rodents which branches
closer to B. microti (4) and the two clusters composed, on
one hand by B. suis biovars 2 and 3, and on the other hand
by B. suis biovars 1 and 4 (4). The problem with this latter
cluster is the close phylogenetic relationship of B. canis with
B. suis biovar 4 (4), which requires an idiosyncratic solution.
The correct classification of Brucella species is particularly
relevant in countries like Costa Rica, in which B. melitensis
and B. suis are absent (65), or in countries in which bovine,
caprine, and swine brucellosis have been eradicated from
livestock, but that still have pathogenic Brucella infecting wildlife
(66). In this regard, the differential diagnosis of the various
Brucella species and strains is a requirement for taking the
infection source.
Brucella sp. BCCN84.3 is a species nova. More isolates of
this bacterium are necessary and additional epidemiological and
biological information needs to be collected before assigning the
corresponding taxonomical species name. In spite of this, and
taking into account the difficulties surrounding the debate on the
Brucella species concept (5, 7), it is mandatory to describe the
extant taxonomical entities in order to understand the dispersion
and evolution of these important pathogens.
The fact that Brucella sp. BCCN84.3. has the ability to
invade the reproductive tract of dogs, may favor the venereal
transmission of this bacterium, as it the case of B. canis which
rapidly disperse in kennel facilities. We do not know the zoonotic
potential of Brucella sp. BCCN84.3. However, it is a smooth strain
that possesses all the virulent machinery for being pathogenic for
humans and other animals. Moreover, the fact that it was isolated
from a domestic dog increases the zoonotic risk.
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